Bass & Boney Pharmaceuticals, Inc. an A+ rating with the BBB.

Click to verify BBB accreditation and to see a BBB report.

SITE DIRECTORY

Home Page

Etiology: The Cause
and Cure for Eczema

Ingredients of
Eczema-Ltd III

How to Use
and Apply

Eczema Types

Eczema Rashes & Treatment

Natural Treatment:
Lifestyle Changes

Eczema Treatments

Order
Eczema-Ltd III
By Credit Card, Debit card, PayPal, Check or Money Order

FAQ

Shipping Information

Progress Follow-up
Form

References

This page lists references for further reading about eczema, including medications used in the treatment of eczema and other skin conditions that co-exist with eczema, such as rosacea, acne, psoriasis and dermatitis.

  1. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients. J Pediatr 1985;107:669.
  2. Adinoff AD, Tellez P, Clark RAF. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol. 1988;81:736.
  3. Norris P, Schofield O, Camp R. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol 1988;118:435.
  4. Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991;24:1097.
  5. Nassif A, Chan SC, Storrs FJ, et al. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 1994;130:1402.
  6. Sampson HA. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Immunol 1988;81:635.
  7. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. 'Spontaneous' basophil histamine release and histamine releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321:228.
  8. Platts-Mills TAE, Mitchell EB, Rowntree S, et al. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233.
  9. Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653.
  10. White A, Horne DJ, Varigos GA. Psychological profile of the atopic eczema patient. Australas J Dermatol 1990;31:13.
  11. Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993;37:637.
  12. Noren P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol 1989;121:359.
  13. Melin L, Frederiksen T, Noren P, et al. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467.
  14. Horne DJ, White AE, Varigos GA. A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 1989;62:241.
  15. Haynes SN, Wilson CC, Jaffe PG, et al. Biofeedback treatment of atopic dermatitis: controlled case studies of eight cases. Biofeedback Self Regul 1979;4:195.
  16. Hauser C, Prins C, Lacour M. The role of infectious agents. In: Leung DYM, ed. Atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co, 1996:67.
  17. Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189.
  18. Novelli VM, Atherton DJ, Marshall WC. Eczema herpeticum. Clinical and laboratory features. Clin Pediatr 1988;27:231.
  19. Bork K, Brauninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024.
  20. Kieffer M, Bergbrant IM, Faergemann J, et al. Immune reactions to Pityro-sporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739.














Prev / Next